DocSym
β
Searchsearch
Search
(Y49.7) Psychostimulants with abuse potential
More details coming soon
41 630 in individuals diagnosis psychostimulants with abuse potential confirmed
2 424 deaths with diagnosis psychostimulants with abuse potential
6% mortality rate associated with the disease psychostimulants with abuse potential
Diagnosis psychostimulants with abuse potential is diagnosed Women are 41.95% more likely than Men
12 083
Men receive the diagnosis psychostimulants with abuse potential
710 (5.9 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
29 547
Women receive the diagnosis psychostimulants with abuse potential
1 714 (5.8 %)Died from this diagnosis.
Risk Group for the Disease psychostimulants with abuse potential - Men aged 15-19 and Women aged 20-24
In Men diagnosis is most often set at age 5-9, 15-29, 35-54, 65-79
Less common in men the disease occurs at Age 0-5, 10-14, 30-34, 55-64, 80-95+Less common in women the disease occurs at Age 0-5, 80-84, 90-95+
In Women diagnosis is most often set at age 5-79, 85-89
Disease Features psychostimulants with abuse potential
Absence or low individual and public risk
Psychostimulants with abuse potential - what does this mean
Psychostimulants with abuse potential are drugs that stimulate the central nervous system, increasing alertness, energy, and concentration. when taken in large doses or taken more often than prescribed, these drugs can lead to physical and psychological dependence, as well as a variety of adverse health effects.
What happens during the disease - psychostimulants with abuse potential
Psychostimulants with abuse potential lead to an increase in dopamine and norepinephrine in the brain, which can create a feeling of euphoria and increased energy. this can lead to an increase in the desire to take the drugs, creating an addictive cycle that can be difficult to break. long-term use can lead to changes in the brain's reward system, resulting in decreased sensitivity to natural rewards and an increased desire for the drug.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical Exam
- Blood Tests
- Urine Tests
- Psychological Evaluations
- Brain Imaging Tests
- Genetic Tests
- Drug Screening Tests
- Interview with the Patient
- Family History Review
Treatment and Medical Assistance
Main Goal: To reduce the potential for abuse of psychostimulants.
- Educating patients and their families about the potential risks associated with psychostimulant use.
- Monitoring the patient's use of the psychostimulant.
- Developing an individualized treatment plan to address the patient's needs.
- Prescribing psychostimulants only when necessary and appropriate.
- Using the lowest effective dose of psychostimulants.
- Regularly assessing the patient's response to the psychostimulant.
- Encouraging the patient to use non-pharmacologic treatments in combination with psychostimulant use.
- Providing psychosocial support and counseling to the patient and their family.
- Referring the patient to a substance abuse treatment program, if necessary.
10 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Psychostimulants with abuse potential - Prevention
Psychostimulants with abuse potential can be prevented by educating individuals on the risks of using these drugs, providing access to treatment for those who have already started to abuse them, and monitoring the use of these drugs through prescription tracking systems.